相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Neoplastic cells are a rare component in human glioblastoma microvasculature
Fausto J. Rodriguez et al.
Oncotarget (2015)
TIE2-expressing monocytes: A novel cellular biomarker for hepatocellular carcinoma?
Michele De Palma et al.
HEPATOLOGY (2013)
Systemic anti-vascular endothelial growth factor therapies induce a painful sensory neuropathy
An Verheyen et al.
BRAIN (2012)
Receptor Talk and Tumor Cell Walk in Glioblastoma
Lena Claesson-Welsh
CANCER CELL (2012)
VEGF Inhibits Tumor Cell Invasion and Mesenchymal Transition through a MET/VEGFR2 Complex
Kan V. Lu et al.
CANCER CELL (2012)
Intussusceptive microvascular growth in tumors
Domenico Ribatti et al.
CANCER LETTERS (2012)
Increased Survival of Glioblastoma Patients Who Respond to Antiangiogenic Therapy with Elevated Blood Perfusion
A. Gregory Sorensen et al.
CANCER RESEARCH (2012)
Anti-VEGF/VEGFR Therapy for Cancer: Reassessing the Target
Basel Sitohy et al.
CANCER RESEARCH (2012)
SnapShot: Tumor Angiogenesis
Rakesh K. Jain et al.
CELL (2012)
Born to Die Blood Vessel Regression Research Coming of Age
Claudia Korn et al.
CIRCULATION (2012)
Plasma Biomarkers as Predictors of Outcome in Patients with Advanced Hepatocellular Carcinoma
Josep M. Llovet et al.
CLINICAL CANCER RESEARCH (2012)
Is there a world beyond bevacizumab in targeting angiogenesis in glioblastoma?
Katharina Seystahl et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2012)
Expression of vascular Notch ligands Delta-like 4 and Jagged-1 in glioblastoma
Adrian M. Jubb et al.
HISTOPATHOLOGY (2012)
Glioblastoma-derived Tumor Cells Induce Vasculogenic Mimicry through Flk-1 Protein Activation
Ralph Francescone et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Targeting the Angiopoietin/Tie2 Pathway: Cutting Tumor Vessels With a Double-Edged Sword?
Tina Cascone et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Endothelial Wnt/β-catenin signaling inhibits glioma angiogenesis and normalizes tumor blood vessels by inducing PDGF-B expression
Marco Reis et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Autocrine VEGF-VEGFR2-Neuropilin-1 signaling promotes glioma stem-like cell viability and tumor growth
Petra Hamerlik et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Safety of concurrent bevacizumab therapy and anticoagulation in glioma patients
Andrew D. Norden et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
A clinical trial of bevacizumab, temozolomide, and radiation for newly diagnosed glioblastoma
Ashwatha Narayana et al.
JOURNAL OF NEUROSURGERY (2012)
Transcriptional profiling of human glioblastoma vessels indicates a key role of VEGF-A and TGFβ2 in vascular abnormalization
Lothar C. Dieterich et al.
JOURNAL OF PATHOLOGY (2012)
Cardiovascular and Systemic Microvascular Effects of Anti-Vascular Endothelial Growth Factor Therapy for Cancer
J. Todd Belcik et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Effects of Angiopoietin-2-Blocking Antibody on Endothelial Cell-Cell Junctions and Lung Metastasis
Tanja Holopainen et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
Notch-dependent VEGFR3 upregulation allows angiogenesis without VEGF-VEGFR2 signalling
Rui Benedito et al.
NATURE (2012)
Overcoming disappointing results with antiangiogenic therapy by targeting hypoxia
Annamaria Rapisarda et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2012)
Cilengitide Treatment for Malignant Glioma: Current Status and Future Direction
Kazuhiko Kurozumi et al.
NEUROLOGIA MEDICO-CHIRURGICA (2012)
The Shear Stress-Induced Transcription Factor KLF2 Affects Dynamics and Angiopoietin-2 Content of Weibel-Palade Bodies
Ellen L. van Agtmaal et al.
PLOS ONE (2012)
Suppression of Tumor Invasion and Metastasis by Concurrent Inhibition of c-Met and VEGF Signaling in Pancreatic Neuroendocrine Tumors
Barbara Sennino et al.
CANCER DISCOVERY (2012)
Controlling escape from angiogenesis inhibitors
Barbara Sennino et al.
NATURE REVIEWS CANCER (2012)
Angiopoietin-2 promotes myeloid cell infiltration in a β2-integrin-dependent manner
Alexander Scholz et al.
BLOOD (2011)
Multiple Effects of Angiopoietin-2 Blockade on Tumors
Claire E. Lewis et al.
CANCER CELL (2011)
VEGF and c-Met Blockade Amplify Angiogenesis Inhibition in Pancreatic Islet Cancer
Weon-Kyoo You et al.
CANCER RESEARCH (2011)
Myeloid Biomarkers Associated with Glioblastoma Response to Anti-VEGF Therapy with Aflibercept
John F. de Groot et al.
CLINICAL CANCER RESEARCH (2011)
Specifically Targeting Angiopoietin-2 Inhibits Angiogenesis, Tie2-Expressing Monocyte Infiltration, and Tumor Growth
Hanhua Huang et al.
CLINICAL CANCER RESEARCH (2011)
Vascular endothelial growth factor (VEGF) isoform regulation of early forebrain development
Diane C. Darland et al.
DEVELOPMENTAL BIOLOGY (2011)
Molecular MRI assessment of vascular endothelial growth factor receptor-2 in rat C6 gliomas
Ting He et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2011)
Clinical significance of vasculogenic mimicry in human gliomas
Xiao-mei Liu et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
CANCER Macrophages limit chemotherapy
Michele De Palma et al.
NATURE (2011)
Molecular mechanisms and clinical applications of angiogenesis
Peter Carmeliet et al.
NATURE (2011)
Tumor-associated macrophages infiltration is associated with peritumoral lymphangiogenesis and poor prognosis in lung adenocarcinoma
Bi Cheng Zhang et al.
MEDICAL ONCOLOGY (2011)
The paradoxical effect of bevacizumab in the therapy of malignant gliomas
Eric M. Thompson et al.
NEUROLOGY (2011)
Vascular endothelial growth factor receptor 2 (VEGFR-2) signalling activity in paediatric pilocytic astrocytoma is restricted to tumour endothelial cells
A. H. Sikkema et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2011)
VEGFR2 Expression and TGF-beta Signaling in Initial and Recurrent High-Grade Human Glioma
Elizabeth A. Kuczynski et al.
ONCOLOGY (2011)
Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma
Olivier Keunen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
The synthetic Tie2 agonist peptide vasculotide protects against vascular leakage and reduces mortality in murine abdominal sepsis
Philipp Kuempers et al.
CRITICAL CARE (2011)
Dll4-Notch signaling as a therapeutic target in tumor angiogenesis
Frank Kuhnert et al.
VASCULAR CELL (2011)
Bevacizumab for the Treatment of Recurrent Glioblastoma
Marc C. Chamberlain
CLINICAL MEDICINE INSIGHTS-ONCOLOGY (2011)
Identification of serum angiopoietin-2 as a biomarker for clinical outcome of colorectal cancer patients treated with bevacizumab-containing therapy
V. Goede et al.
BRITISH JOURNAL OF CANCER (2010)
Double Antiangiogenic Protein, DAAP, Targeting VEGF-A and Angiopoietins in Tumor Angiogenesis, Metastasis, and Vascular Leakage
Young Jun Koh et al.
CANCER CELL (2010)
Recruitment of Myeloid but not Endothelial Precursor Cells Facilitates Tumor Regrowth after Local Irradiation
Sergey V. Kozin et al.
CANCER RESEARCH (2010)
Angiopoietin-2 Regulates Gene Expression in TIE2-Expressing Monocytes and Augments Their Inherent Proangiogenic Functions
Seth B. Coffelt et al.
CANCER RESEARCH (2010)
Immunity, Inflammation, and Cancer
Sergei I. Grivennikov et al.
CELL (2010)
Angiopoietin-2 Interferes with Anti-VEGFR2-Induced Vessel Normalization and Survival Benefit in Mice Bearing Gliomas
Sung-Suk Chae et al.
CLINICAL CANCER RESEARCH (2010)
Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice
Mitomu Kioi et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
A Human Monoclonal Anti-ANG2 Antibody Leads to Broad Antitumor Activity in Combination with VEGF Inhibitors and Chemotherapy Agents in Preclinical Models
Jeffrey L. Brown et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Chronic DLL4 blockade induces vascular neoplasms
Minhong Yan et al.
NATURE (2010)
Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells
Lucia Ricci-Vitiani et al.
NATURE (2010)
Glioblastoma stem-like cells give rise to tumour endothelium
Rong Wang et al.
NATURE (2010)
Tumor invasion after treatment of glioblastoma with bevacizumab: radiographic and pathologic correlation in humans and mice
John F. de Groot et al.
NEURO-ONCOLOGY (2010)
Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma
Christian Steidl et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Axon Guidance Molecules in Vascular Patterning
Ralf H. Adams et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
VEGF in the nervous system
Jeffrey M. Rosenstein et al.
ORGANOGENESIS (2010)
Targeting the ANGPT-TIE2 pathway in malignancy
Hanhua Huang et al.
NATURE REVIEWS CANCER (2010)
Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis
John M. L. Ebos et al.
CANCER CELL (2009)
Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis
Marta Paez-Ribes et al.
CANCER CELL (2009)
Direct Evidence that Bevacizumab, an Anti-VEGF Antibody, Up-regulates SDF1α, CXCR4, CXCL6, and Neuropilin 1 in Tumors from Patients with Rectal Cancer
Lei Xu et al.
CANCER RESEARCH (2009)
The Notch Ligands Dll4 and Jagged1 Have Opposing Effects on Angiogenesis
Rui Benedito et al.
CELL (2009)
Antimyeloangiogenic Therapy for Cancer by Inhibiting PIGF
Sonja Loges et al.
CLINICAL CANCER RESEARCH (2009)
Expression of the macrophage antigen CD163 in rectal cancer cells is associated with early local recurrence and reduced survival time
Ivan Shabo et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Safety, Pharmacokinetics, and Antitumor Activity of AMG 386, a Selective Angiopoietin Inhibitor, in Adult Patients With Advanced Solid Tumors
Roy S. Herbst et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Branching morphogenesis and antiangiogenesis candidates: tip cells lead the way
Peter Carmeliet et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2009)
Antiangiogenic therapies for high-grade glioma
Andrew D. Norden et al.
NATURE REVIEWS NEUROLOGY (2009)
Role and Therapeutic Potential of VEGF in the Nervous System
Carmen Ruiz De Almodovar et al.
PHYSIOLOGICAL REVIEWS (2009)
Flt-1 signaling in macrophages promotes glioma growth in vivo
Mark Kerber et al.
CANCER RESEARCH (2008)
VEGF Trap induces antiglioma effect at different stages of disease
Candelaria Gomez-Manzano et al.
NEURO-ONCOLOGY (2008)
Molecular origins of cancer: Tumor angiogenesis
Robert S. Kerbel
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Modes of resistance to anti-angiogenic therapy
Gabriele Bergers et al.
NATURE REVIEWS CANCER (2008)
The role of myeloid cells in the promotion of tumour angiogenesis
Craig Murdoch et al.
NATURE REVIEWS CANCER (2008)
Tie2-expressing monocytes: regulation of tumor angiogenesis and therapeutic implications
Michele De Palma et al.
TRENDS IN IMMUNOLOGY (2007)
Anti-PIGF inhibits growth of VEGF(R)-Inhibitor-Resistant tumors without affecting healthy vessels
Christian Fischer et al.
CELL (2007)
Bevacizumab plus irinotecan in recurrent glioblastoma multiforme
James J. Vredenburgh et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Regulation of vascular morphogenesis by Notch signaling
Cristina Roca et al.
GENES & DEVELOPMENT (2007)
Tie2-expressing monocytes and tumor angiogenesis: Regulation by hypoxia and angiopoletin-2
Claire E. Lewis et al.
CANCER RESEARCH (2007)
Autocrine VEGF signaling is required for vascular homeostasis
Sunyoung Lee et al.
CELL (2007)
Hypoxia can induce c-Met expression in glioma cells and enhance SF/HGF-induced cell migration
Carmen Eckerich et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Different networks, common growth factors: shared growth factors and receptors of the vascular and the nervous system
Sabine Raab et al.
ACTA NEUROPATHOLOGICA (2007)
Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: Potential targets of anti-cancer therapy
A Sica et al.
EUROPEAN JOURNAL OF CANCER (2006)
Angiopoietin-2 sensitizes endothelial cells to TNF-α and has a crucial role in the induction of inflammation
U Fiedler et al.
NATURE MEDICINE (2006)
VEGF-induced adult neovascularization: Recruitment, retention, and role of accessory cells
M Grunewald et al.
CELL (2006)
Tie2 identifies a hematopoietic monocytes required for tumor lineage of proangiogenic vessel formation and a mesenchymal population of pericyte progenitors
M De Palma et al.
CANCER CELL (2005)
Does vasculogenic mimicry exist in astrocytoma?
WY Yue et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2005)
Normalization of tumor vasculature: An emerging concept in antiangiogenic therapy
RK Jain
SCIENCE (2005)
Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS
E Storkebaum et al.
NATURE NEUROSCIENCE (2005)
Vascular endothelial growth factor (VEGF) receptor neuropilin-1's distribution in astrocytic tumors
H Broholm et al.
APMIS (2004)
Pseudopalisades in glioblastoma are hypoxic, express extracellular matrix proteases, and are formed by an actively migrating cell population
DJ Brat et al.
CANCER RESEARCH (2004)
VEGF links hippocampal activity with neurogenesis, learning and memory
L Cao et al.
NATURE GENETICS (2004)
VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death
D Lambrechts et al.
NATURE GENETICS (2003)
Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene
S Pennacchietti et al.
CANCER CELL (2003)
Vascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo
KL Jin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
VEGF-Trap: A VEGF blocker with potent antitumor effects
J Holash et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration
B Oosthuyse et al.
NATURE GENETICS (2001)
Tie receptors: New modulators of angiogenic and lymphangiogenic responses
N Jones et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2001)
Endothelial cells of tumor vessels: Abnormal but not absent
DM McDonald et al.
CANCER AND METASTASIS REVIEWS (2000)
Intussusceptive angiogenesis - Its role in embryonic vascular network formation
V Djonov et al.
CIRCULATION RESEARCH (2000)
分享论文
